Thursday, May 02, 2024
MMI has proudly announced the completion of its first clinical cases in the United States using the Symani® Surgical System. These procedures were performed at Penn Medicine, Penn Presbyterian Medical Center, in collaboration with the Department of Orthopaedic Surgery and the Department of Surgery’s Division of Plastic Surgery.
The historic surgeries focused on reconstructive extremity microsurgeries. One procedure involved a "free bone transfer" on a patient with a traumatic injury, where a segment of bone and skin was transferred from the leg to repair a damaged bone in the forearm.
The second case addressed a patient at risk of leg amputation due to an infected knee prosthesis with soft tissue deficiency. Muscle and skin from the patient's back were transplanted to repair the knee wound, with the robotic system used to reconnect blood vessels.
CEO at MMI, highlighted the significance of these cases, stating they mark a milestone in expanding the Symani Surgical System's reach.
He emphasized the system's potential to revolutionize surgical innovation, providing expanded treatment options for patients requiring complex microsurgical techniques.
The Symani Surgical System recently received De Novo Classification from the U.S. Food and Drug Administration (FDA), making it the only commercially available platform in the U.S. for reconstructive microsurgery. It addresses the challenges of microsurgery and supermicrosurgery, enabling surgeons to perform intricate procedures on small anatomical structures like blood and lymphatic vessels.
Advancement aims to enhance patient outcomes, empower surgeons, and support hospitals in expanding their surgical capabilities.
Source: businesswire.com
